Identifying cancer predisposition genes and their pathogenic variants is a powerful way for clinicians to assess cancer risk and implement disease management plans. Genomic methodologies, such as quantitative PCR (qPCR), digital PCR (dPCR), microarrays, and capillary electrophoresis, facilitate cancer gene detection.
Download this ebook from Thermo Fisher Scientific to learn how scientists leverage genomics to detect cancer signatures